Literature DB >> 15086428

Chronic hepatotoxicity following 6-thioguanine therapy for childhood acute lymphoblastic leukaemia.

Barbara Piel, Sucheta Vaidya, Donna Lancaster, Mary Taj, Kathy Pritchard-Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15086428     DOI： 10.1111/j.1365-2141.2004.04919.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  4 in total

1.  Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial.

Authors:  Linda C Stork; Yousif Matloub; Emmett Broxson; Mei La; Rochelle Yanofsky; Harland Sather; Ray Hutchinson; Nyla A Heerema; April D Sorrell; Margaret Masterson; Archie Bleyer; Paul S Gaynon
Journal:  Blood       Date:  2010-02-01       Impact factor: 22.113

Review 2.  Hepato-biliary late effects in survivors of childhood and adolescent cancer: a report from the Children's Oncology Group.

Authors:  Sharon Castellino; Andrew Muir; Ami Shah; Sheila Shope; Kevin McMullen; Kathy Ruble; Ashley Barber; Andrew Davidoff; Melissa M Hudson
Journal:  Pediatr Blood Cancer       Date:  2010-05       Impact factor: 3.167

3.  A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with inflammatory bowel disease.

Authors:  Alexander Teml; Matthias Schwab; Daan W Hommes; Sven Almer; Milan Lukas; Thomas Feichtenschlager; Timothy Florin; Julia Seiderer; Wolfgang Petritsch; Bernd Bokemeyer; Wolfgang Kreisel; Klaus R Herrlinger; Peter Knoflach; Bruno Bonaz; Thomas Klugmann; Hans Herfarth; Nikolaus Pedarnig; Walter Reinisch
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

4.  Thiopurines induce oxidative stress in T-lymphocytes: a proteomic approach.

Authors:  Misbah Misdaq; Sonia Ziegler; Nicolas von Ahsen; Michael Oellerich; Abdul R Asif
Journal:  Mediators Inflamm       Date:  2015-03-22       Impact factor: 4.711
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.